Literature DB >> 6419762

Nifedipine increases and glyceryl trinitrate decreases apparent liver blood flow in normal subjects.

J Feely.   

Abstract

The effects of sublingual nifedipine (10 mg) and of glyceryl trinitrate (500 micrograms), which produce arterial and venous vasodilatation respectively, on indocyanine green estimated apparent liver blood flow (LBF) were studied in six healthy volunteers. Nifedipine significantly increased (33 +/- 12%; mean +/- s.e. mean) and glyceryl trinitrate significantly reduced (18 +/- 3%) LBF. There was a positive relationship (r = 0.92, P less than 0.05) between the reduction in mean arterial pressure produced by nifedipine and the percentage increase in LBF. These results show that single doses of nifedipine and glyceryl trinitrate significantly alter LBF.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6419762      PMCID: PMC1463307          DOI: 10.1111/j.1365-2125.1984.tb05003.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.

Authors:  J CAESAR; S SHALDON; L CHIANDUSSI; L GUEVARA; S SHERLOCK
Journal:  Clin Sci       Date:  1961-08       Impact factor: 6.124

Review 2.  Drug kinetics and hepatic blood flow.

Authors:  C F George
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

3.  Interrelationships of hepatic blood flow, cardiac output, and blood levels of lidocaine in man.

Authors:  R E Stenson; R T Constantino; D C Harrison
Journal:  Circulation       Date:  1971-02       Impact factor: 29.690

4.  Calcium antagonists, nitrates, and new antianginal drugs.

Authors:  D Maclean; J Feely
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-02

5.  Cimetidine alters plasma catecholamine levels and cortisol and aldosterone excretion.

Authors:  J Feely; D Robertson; D P Island; A J Wood
Journal:  N Engl J Med       Date:  1982-04-29       Impact factor: 91.245

6.  Effect of hypotension on liver blood flow and lidocaine disposition.

Authors:  J Feely; D Wade; C B McAllister; G R Wilkinson; D Robertson
Journal:  N Engl J Med       Date:  1982-09-30       Impact factor: 91.245

7.  Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.

Authors:  R D Magorien; D W Triffon; C E Desch; W H Bay; D V Unverferth; C V Leier
Journal:  Ann Intern Med       Date:  1981-07       Impact factor: 25.391

8.  Physiological and pharmacological variability in estimated hepatic blood flow in man.

Authors:  T K Daneshmend; L Jackson; C J Roberts
Journal:  Br J Clin Pharmacol       Date:  1981-05       Impact factor: 4.335

9.  Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension.

Authors:  R J Groszmann; D Kravetz; J Bosch; M Glickman; J Bruix; J Bredfeldt; H O Conn; J Rodes; E H Storer
Journal:  Hepatology       Date:  1982 Nov-Dec       Impact factor: 17.425

10.  Minoxidil increases aldosterone metabolic clearance in hypertensive patients.

Authors:  J H Pratt; C E Grim; C A Parkinson
Journal:  J Clin Endocrinol Metab       Date:  1979-12       Impact factor: 5.958

View more
  24 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

2.  Acute effects of felodipine and nifedipine on hepatic and forearm blood flow in healthy men.

Authors:  B Bengtsson-Hasselgren; O Rönn; L O Blychert; B Edgar; S Raner
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  The interactions between nisoldipine and two beta-adrenoceptor antagonists--atenolol and propranolol.

Authors:  H L Elliott; P A Meredith; C McNally; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

4.  The contribution of nisoldipine-induced changes in liver blood flow to its pharmacokinetics after oral administration.

Authors:  J van Harten; J Burggraaf; M Danhof; P van Brummelen; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

5.  The trans-hepatic extraction of nifedipine.

Authors:  V F Challenor; D G Waller; A G Renwick; B S Gruchy; C F George
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

6.  Effect of nifedipine on serum theophylline concentrations and asthma control.

Authors:  S R Smith; J Wiggins; D E Stableforth; C Skinner; M J Kendall
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

Review 7.  Drug interactions with thrombolytic agents. Current perspectives.

Authors:  A de Boer; J M van Griensven
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

8.  Effect of nifedipine on plasma catecholamines in man at rest and during exercise.

Authors:  G Defer; Y C Guezennec; F Lhoste
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  Circadian changes in estimated hepatic blood flow in healthy subjects.

Authors:  B Lemmer; G Nold
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

10.  Interaction study between nifedipine and recombinant tissue-type plasminogen activator in healthy subjects.

Authors:  A De Boer; C Kluft; F J Kasper; J M Kroon; H C Schoemaker; D D Breimer; P A Soons; A F Cohen
Journal:  Br J Clin Pharmacol       Date:  1993-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.